Description
Seeking men and women with Amyotrophic Lateral Sclerosis (ALS) to participate in a research trial to test several different investigational treatments.
Overview
We are comparing a series of different investigational drug regimens to placebo (looks like the drug but contains no active medicine). Participants have at 75% chance of receiving one of the investigational drug regimens and a 25% chance of receiving the placebo.
What we're hoping for
We hope that the investigational treatments will slow the progression of Amyotrophic Lateral Sclerosis (ALS) or improve ALS symptoms.
Additional Information
ClinicalTrials.gov Identifier: NCT04297683